Assessment of preference for hormonal treatment-related health states among patients with breast cancer

Xing Yu Tan, Maung Maung Aung, Mei Ing Ngai, Feng Xie, Yu Ko

研究成果: 雜誌貢獻文章

3 引文 (Scopus)

摘要

Objectives: 1) To obtain preference scores from patients with breast cancer in Singapore for different stages of breast cancer and hormonal therapy-related adverse effects, and 2) to determine the association of patients' demographic and clinical characteristics with those preference scores. Methods: A total of 22 health states were used to elicit preference values from 64 patients with breast cancer. At each interview, 14 health states were randomly selected and rated by the patient using the visual analogue scale and standard gamble methods to derive health state preference scores, which were recalibrated to the scale of 0 (death) and 1 (perfect health). Results: Mean adjusted visual analogue scale scores ranged from 0.25 (no recurrence with ischemic cerebrovascular events) to 0.82 (no recurrence with no adverse effects). Mean adjusted standard gamble scores ranged from 0.31 (distant recurrence with chemotherapy-related adverse effects) to 0.80 (no recurrence with no adverse effects). Adverse effects ischemic cerebrovascular events and spine fracture resulted in the greatest decline in health state preference scores. Age, ethnicity, education level, and prior chemotherapy were associated with preference scores. Having children was not found to be associated with the preference scores. Conclusions: Taking into account disease progression and hormonal therapy-related adverse effects as well as their impact on health-related quality of life, this study quantifies patients' preference for various breast cancer-related health states. The findings offer valuable information for future cost-utility analysis of breast cancer treatments.

原文英語
頁(從 - 到)27-32
頁數6
期刊Value in Health Regional Issues
3
發行號1
DOIs
出版狀態已發佈 - 2014
對外發佈Yes

指紋

Breast Neoplasms
Health
Recurrence
Patient Preference
Visual Analog Scale
Therapeutics
Drug Therapy
Singapore
Cost-Benefit Analysis
Disease Progression
Breast cancer
Health state
Spine
Quality of Life
Demography
Interviews
Education
Standard gamble
Visual analogue scale
Chemotherapy

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Economics, Econometrics and Finance (miscellaneous)

引用此文

Assessment of preference for hormonal treatment-related health states among patients with breast cancer. / Tan, Xing Yu; Aung, Maung Maung; Ngai, Mei Ing; Xie, Feng; Ko, Yu.

於: Value in Health Regional Issues, 卷 3, 編號 1, 2014, p. 27-32.

研究成果: 雜誌貢獻文章

Tan, Xing Yu ; Aung, Maung Maung ; Ngai, Mei Ing ; Xie, Feng ; Ko, Yu. / Assessment of preference for hormonal treatment-related health states among patients with breast cancer. 於: Value in Health Regional Issues. 2014 ; 卷 3, 編號 1. 頁 27-32.
@article{527bdc78157548638c0f1f42dc2233ad,
title = "Assessment of preference for hormonal treatment-related health states among patients with breast cancer",
abstract = "Objectives: 1) To obtain preference scores from patients with breast cancer in Singapore for different stages of breast cancer and hormonal therapy-related adverse effects, and 2) to determine the association of patients' demographic and clinical characteristics with those preference scores. Methods: A total of 22 health states were used to elicit preference values from 64 patients with breast cancer. At each interview, 14 health states were randomly selected and rated by the patient using the visual analogue scale and standard gamble methods to derive health state preference scores, which were recalibrated to the scale of 0 (death) and 1 (perfect health). Results: Mean adjusted visual analogue scale scores ranged from 0.25 (no recurrence with ischemic cerebrovascular events) to 0.82 (no recurrence with no adverse effects). Mean adjusted standard gamble scores ranged from 0.31 (distant recurrence with chemotherapy-related adverse effects) to 0.80 (no recurrence with no adverse effects). Adverse effects ischemic cerebrovascular events and spine fracture resulted in the greatest decline in health state preference scores. Age, ethnicity, education level, and prior chemotherapy were associated with preference scores. Having children was not found to be associated with the preference scores. Conclusions: Taking into account disease progression and hormonal therapy-related adverse effects as well as their impact on health-related quality of life, this study quantifies patients' preference for various breast cancer-related health states. The findings offer valuable information for future cost-utility analysis of breast cancer treatments.",
keywords = "Breast cancer, Preference, Standard gamble, VAS",
author = "Tan, {Xing Yu} and Aung, {Maung Maung} and Ngai, {Mei Ing} and Feng Xie and Yu Ko",
year = "2014",
doi = "10.1016/j.vhri.2013.12.002",
language = "English",
volume = "3",
pages = "27--32",
journal = "Value in Health Regional Issues",
issn = "2212-1099",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Assessment of preference for hormonal treatment-related health states among patients with breast cancer

AU - Tan, Xing Yu

AU - Aung, Maung Maung

AU - Ngai, Mei Ing

AU - Xie, Feng

AU - Ko, Yu

PY - 2014

Y1 - 2014

N2 - Objectives: 1) To obtain preference scores from patients with breast cancer in Singapore for different stages of breast cancer and hormonal therapy-related adverse effects, and 2) to determine the association of patients' demographic and clinical characteristics with those preference scores. Methods: A total of 22 health states were used to elicit preference values from 64 patients with breast cancer. At each interview, 14 health states were randomly selected and rated by the patient using the visual analogue scale and standard gamble methods to derive health state preference scores, which were recalibrated to the scale of 0 (death) and 1 (perfect health). Results: Mean adjusted visual analogue scale scores ranged from 0.25 (no recurrence with ischemic cerebrovascular events) to 0.82 (no recurrence with no adverse effects). Mean adjusted standard gamble scores ranged from 0.31 (distant recurrence with chemotherapy-related adverse effects) to 0.80 (no recurrence with no adverse effects). Adverse effects ischemic cerebrovascular events and spine fracture resulted in the greatest decline in health state preference scores. Age, ethnicity, education level, and prior chemotherapy were associated with preference scores. Having children was not found to be associated with the preference scores. Conclusions: Taking into account disease progression and hormonal therapy-related adverse effects as well as their impact on health-related quality of life, this study quantifies patients' preference for various breast cancer-related health states. The findings offer valuable information for future cost-utility analysis of breast cancer treatments.

AB - Objectives: 1) To obtain preference scores from patients with breast cancer in Singapore for different stages of breast cancer and hormonal therapy-related adverse effects, and 2) to determine the association of patients' demographic and clinical characteristics with those preference scores. Methods: A total of 22 health states were used to elicit preference values from 64 patients with breast cancer. At each interview, 14 health states were randomly selected and rated by the patient using the visual analogue scale and standard gamble methods to derive health state preference scores, which were recalibrated to the scale of 0 (death) and 1 (perfect health). Results: Mean adjusted visual analogue scale scores ranged from 0.25 (no recurrence with ischemic cerebrovascular events) to 0.82 (no recurrence with no adverse effects). Mean adjusted standard gamble scores ranged from 0.31 (distant recurrence with chemotherapy-related adverse effects) to 0.80 (no recurrence with no adverse effects). Adverse effects ischemic cerebrovascular events and spine fracture resulted in the greatest decline in health state preference scores. Age, ethnicity, education level, and prior chemotherapy were associated with preference scores. Having children was not found to be associated with the preference scores. Conclusions: Taking into account disease progression and hormonal therapy-related adverse effects as well as their impact on health-related quality of life, this study quantifies patients' preference for various breast cancer-related health states. The findings offer valuable information for future cost-utility analysis of breast cancer treatments.

KW - Breast cancer

KW - Preference

KW - Standard gamble

KW - VAS

UR - http://www.scopus.com/inward/record.url?scp=84897415108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897415108&partnerID=8YFLogxK

U2 - 10.1016/j.vhri.2013.12.002

DO - 10.1016/j.vhri.2013.12.002

M3 - Article

AN - SCOPUS:84897415108

VL - 3

SP - 27

EP - 32

JO - Value in Health Regional Issues

JF - Value in Health Regional Issues

SN - 2212-1099

IS - 1

ER -